Stockholm Stock Exchange | Large Cap
Sobi
+20.12%
Latest
+5.53%
3 months
BerenbergSEBPareto SecuritiesJefferiesSEB EquitiesDNB MarketsKepler CheuvreuxNordea MarketsCarnegieDeutsche BankMorgan StanleyRBCHSBCRBC Capital MarketsDNBHandelsbanken Capital MarketsMorningstarDanske Bank MarketsDanske BankJefferies InternationalBarclaysHandelsbankenABG Sundal Collier

About The Company

Swedish Orphan Biovitrum (Sobi) is a pharmaceutical company with two focus areas: haemophilia and rare diseases. Sobi is a merger of Swedish Orphan and Biovitrum. The company has its premises in Karolinska Institutet Science Park in Solna.
Wikipedia